Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Amortization of Deferred Charges (2019)

Historic Amortization of Deferred Charges for Niagen Bioscience (NAGE) over the last 1 years, with Q3 2019 value amounting to $294000.0.

  • Niagen Bioscience's Amortization of Deferred Charges changed N/A to $294000.0 in Q3 2019 from the same period last year, while for Dec 2019 it was $846000.0, marking a year-over-year change of. This contributed to the annual value of $846000.0 for FY2019, which is N/A changed from last year.
  • Per Niagen Bioscience's latest filing, its Amortization of Deferred Charges stood at $294000.0 for Q3 2019.
  • Over the past 5 years, Niagen Bioscience's Amortization of Deferred Charges peaked at $414000.0 during Q2 2019, and registered a low of $138000.0 during Q1 2019.